{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:34:52Z","timestamp":1778776492215,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004686","name":"Deanship of Scientific Research, King Faisal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jtumed.2020.10.017","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T09:18:03Z","timestamp":1606468683000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells"],"prefix":"10.1016","volume":"16","author":[{"given":"Salah A.","family":"Sheweita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania G.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally A.","family":"Sabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtumed.2020.10.017_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1179\/oeh.2009.15.1.43","article-title":"State of the evidence: the connection between breast cancer and the\u00a0environment","volume":"15","author":"Gray","year":"2009","journal-title":"Int J Occup Environ Health"},{"issue":"7261","key":"10.1016\/j.jtumed.2020.10.017_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases: breast cancer\u2014epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"issue":"1\u20135","key":"10.1016\/j.jtumed.2020.10.017_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsbmb.2006.09.002","article-title":"Aromatase and breast cancer","volume":"102","author":"Brodie","year":"2006","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"10","key":"10.1016\/j.jtumed.2020.10.017_bib4","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1200\/JCO.2001.19.10.2596","article-title":"Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group","volume":"19","author":"Mouridsen","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtumed.2020.10.017_bib5","series-title":"Hormone-dependent cancer","first-page":"155","article-title":"Pharmacology of non-steroidal aromatase inhibitors","author":"Bhatnagar","year":"1996"},{"issue":"3","key":"10.1016\/j.jtumed.2020.10.017_bib6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial","volume":"17","author":"Theriault","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jtumed.2020.10.017_bib7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/sj.bjc.6602691","article-title":"Bone loss and the aromatase inhibitors","volume":"93","author":"Lester","year":"2005","journal-title":"Br J Canc"},{"issue":"5","key":"10.1016\/j.jtumed.2020.10.017_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jtumed.2020.10.017_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in\u00a0vitro and inhibition of bone resorption in\u00a0vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"5","key":"10.1016\/j.jtumed.2020.10.017_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ctrv.2008.02.004","article-title":"Exploring the anti-tumor activity of bisphosphonates in early breast cancer","volume":"34","author":"Winter","year":"2008","journal-title":"Canc Treat Rev"},{"key":"10.1016\/j.jtumed.2020.10.017_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.breast.2018.06.009","article-title":"Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines","volume":"41","author":"Sultan","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.jtumed.2020.10.017_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.onc.1204073","article-title":"Role of direct interaction in BRCA1 inhibition of estrogen receptor activity","volume":"20","author":"Fan","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jtumed.2020.10.017_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0959-437X(01)00269-6","article-title":"The BRCA1\/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity","volume":"12","author":"Baer","year":"2002","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"10.1016\/j.jtumed.2020.10.017_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.8.5.409","article-title":"STAT proteins as novel targets for cancer drug discovery","volume":"8","author":"Turkson","year":"2004","journal-title":"Expert Opin Ther Targets"},{"issue":"21","key":"10.1016\/j.jtumed.2020.10.017_bib15","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"issue":"5332","key":"10.1016\/j.jtumed.2020.10.017_bib16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.jtumed.2020.10.017_bib17","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\u20135","key":"10.1016\/j.jtumed.2020.10.017_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2012.05.008","article-title":"Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction","volume":"132","author":"Schech","year":"2012","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.jtumed.2020.10.017_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13238-010-0010-5","article-title":"The role of BRCA1 in DNA damage response","volume":"1","author":"Wu","year":"2010","journal-title":"Protein Cell"},{"issue":"8","key":"10.1016\/j.jtumed.2020.10.017_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/13543784.2017.1351941","article-title":"Do STAT3 inhibitors have potential in the future for cancer therapy?","volume":"26","author":"Wong","year":"2017","journal-title":"Expet Opin Invest Drugs"},{"issue":"10","key":"10.1016\/j.jtumed.2020.10.017_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","article-title":"Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies","volume":"14","author":"Hormones","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jtumed.2020.10.017_bib22","first-page":"40","article-title":"Immediate administration of zoledronic acid reduces aromatase inhibitor\u2013associated bone loss in postmenopausal women with early breast cancer: 12-month analysis of the E-ZO-FAST trial","volume":"12","author":"Llombart","year":"2012","journal-title":"Clin Breast Canc"},{"key":"10.1016\/j.jtumed.2020.10.017_bib23","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.2147\/OTT.S115058","article-title":"Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole","volume":"9","author":"Sun","year":"2016","journal-title":"OncoTargets Ther"},{"issue":"29","key":"10.1016\/j.jtumed.2020.10.017_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24290","article-title":"Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation","volume":"24","author":"Davis","year":"2020","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1016\/j.jtumed.2020.10.017_bib25","first-page":"155","article-title":"Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model","volume":"9","author":"Yu","year":"2016","journal-title":"Dis Model Mech"},{"issue":"1","key":"10.1016\/j.jtumed.2020.10.017_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1210\/me.2009-0218","article-title":"BRCA1 regulates acetylation and ubiquitination of estrogen receptor-\u03b1","volume":"24","author":"Ma","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.jtumed.2020.10.017_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.arcmed.2017.11.012","article-title":"Combined raloxifene and letrozole for breast cancer patients","volume":"48","author":"Vohora","year":"2017","journal-title":"Arch Med Res"},{"issue":"4","key":"10.1016\/j.jtumed.2020.10.017_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1139\/bcb-2016-0206","article-title":"Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line","volume":"95","author":"Rahideh","year":"2017","journal-title":"Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.jtumed.2020.10.017_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00774-019-01052-6","article-title":"Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma","volume":"38","author":"Jeon","year":"2019","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.jtumed.2020.10.017_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.breast.2017.12.017","article-title":"Combined effects of neoadjuvant letrozole and zoledronic acid on \u03b3\u03b4T cells in postmenopausal women with early-stage breast cancer","volume":"38","author":"Sugie","year":"2018","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.jtumed.2020.10.017_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-018-1491-x","article-title":"Gamma-delta (\u03b3\u03b4) T cells: friend or foe in cancer development?","volume":"16","author":"Zhao","year":"2018","journal-title":"J\u00a0Transl Med"},{"issue":"41","key":"10.1016\/j.jtumed.2020.10.017_bib32","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1038\/sj.onc.1206750","article-title":"Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas","volume":"22","author":"Motiwala","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jtumed.2020.10.017_bib33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.25980","article-title":"Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3","volume":"57","author":"Hou","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jtumed.2020.10.017_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5306\/wjco.v5.i3.248","article-title":"Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer","volume":"5","author":"Zhao","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.jtumed.2020.10.017_bib35","series-title":"Resistance to aromatase inhibitors in breast cancer","first-page":"13","article-title":"Structure, regulation and polymorphisms of the aromatase gene","author":"Harada","year":"2015"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361220301694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361220301694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:28:39Z","timestamp":1761647319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361220301694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1658361220301694"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2020.10.017","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2020.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier Ltd on behalf of Taibah University.","name":"copyright","label":"Copyright"}]}}